Insights On CONTRACT PHARMA MANUFACTURING

  1. Solving The Sequencing Puzzle: Speed, Cost, And Quality 10/28/2025

    Next-generation sequencing (NGS) accelerates therapy development by enabling rapid, cost-effective DNA/RNA analysis crucial for cell and gene therapies, process optimization, and impurity detection.

  2. Onshoring Advantage: 7 Forces Reshaping Global Biologics Manufacturing 10/27/2025

    Policy, trade, and security pressures are fundamentally reshaping global biologics manufacturing. Forward-looking companies are onshoring critical programs to mitigate risks to supply chains, IP, and regulatory timelines.

  3. Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products 10/24/2025

    Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.

  4. How In-House CDMO Analytics Reduce Risk and Cost 10/21/2025

    Integrated analytical capabilities within a CDMO are increasingly preferred to overcome challenges associated with outsourcing analysis in biopharma development and manufacturing.

  5. Collaboration An Untapped Fuel For Driving Biopharma R&D 10/20/2025

    Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.

  6. Development And Manufacture Of A Highly Potent OSD Product 10/20/2025

    Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

  7. TPDs: Developing The Next Generation Of Oral Therapeutics 10/20/2025

    Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.

  8. Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs 10/20/2025

    The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.

  9. How Global Supply Chain Centers Amplify CGT Program Growth 10/20/2025

    Consolidating logistics, cryopreservation, and storage eliminates handoffs and risk. This single-platform approach creates the consistency needed for global compliance and growth.

  10. Hidden Risks In Your Supply Chain: Regulatory Support Can Save Your CGT 10/20/2025

    Unvalidated shipping lanes and incomplete documentation can cause regulatory delays. Proactive qualification and risk assessments are vital for compliance and safeguarding product integrity.